Screening– tag –
-
New Technology
UA Little Rock Secures Grant to Develop 3D Tissue Scaffold Replicating Human Intestinal Villi-Crypt Structures
University of Arkansas at Little Rock News USA Overview Dr. Sujan Ghosh at the University of Arkansas at Little Rock has received a grant to develop a novel 3D tissue scaffold capable of accurately mimicking the villi-crypt structures of... -
New Technology
3D Bioprinting Market Drives Regenerative Medicine and Biomedical Innovation, Accelerated by AI Integration
The Business Research Company Global Overview The 3D bioprinting market is rapidly growing as a pivotal technology driving innovation in regenerative medicine and biomedical fields. This technology combines living cells, biomaterials, an... -
New Technology
Monod Bio Licenses AI-Designed Protein Technologies to SignalChem Biotech for Accelerated Custom Luminescent Assay Development
The Scientist Global Overview AI-driven protein design company Monod Bio has entered into a non-exclusive licensing agreement with SignalChem Biotech, enabling the integration of Monod Bio's LuxSit de novo luciferase technology and NovoB... -
New Technology
AI Accelerates Drug Discovery: AlphaFold, Generative Models Drive R&D Efficiency & Clinical Pipeline Growth
Markets Insider USA Overview AI has dramatically accelerated drug discovery over the past five years through advancements in protein structure prediction, generative chemistry, and phenotypic screening. Tools like DeepMind's AlphaFold ha... -
New Technology
Frontiers in Highlights AI and Machine Learning for LNP Design, Accelerating Advanced Drug Delivery System Development
Frontiers in International Overview This article discusses how AI and machine learning are revolutionizing the design and screening of lipid nanoparticle (LNP) formulations for advanced drug delivery systems. AI can predict LNP propertie... -
iPS Cells & Regenerative Medicine
AI-Guided 3D Bioreactors Revolutionize iPSC Manufacturing: Scaling Up and Cutting Costs for Accelerated Commercialization
Wiley Analytical Science USA Overview AI-guided 3D bioreactor technology is revolutionizing iPSC manufacturing, enabling reliable, efficient, and scalable production of pluripotent stem cells (PSCs). This innovative platform facilitates ... -
New Technology
CRISPR/Cas9 Evolves into Multi-Tool: Expanding Applications from Leukemia Screening to CAR-T Cell Engineering and Epigenome Editing
NHSJS USA Overview CRISPR/Cas9 technology has significantly evolved, broadening its applications from screening leukemia mutations to enhancing CAR-T cells' cancer recognition and precisely controlling gene expression through epigenome e... -
New Technology
Next-Generation Bioinks Create New Opportunities in Tissue Engineering and Drug Discovery via 3D Bioprinting
ACS Publications USA Overview Advances in next-generation bioinks are significantly propelling the fields of tissue engineering and regenerative medicine through 3D bioprinting technology. These bioinks are essential for creating microen... -
New Technology
Bayer Continues Support for BlueRock Therapeutics’ CLARICO Eye Study of iPSC-Derived Photoreceptor Therapy OpCT-001 for Genetic Ocular Disease
TipRanks USA Overview Bayer AG announced continued support for BlueRock Therapeutics' CLARICO eye study, a Phase 1/2a trial evaluating the safety and early efficacy signals of OpCT-001, an iPSC-derived photoreceptor progenitor cell thera... -
New Technology
3D Bioprinting Advances Tumor Organoid Modeling and Bone Regeneration Spheroids
PMC - NIH USA Overview 3D bioprinting technology is revolutionizing cancer modeling by enabling the construction of human tumor organoids that accurately recapitulate complex tumor microenvironments for high-throughput drug screening. Co...